(WNDU) - A PET scan is an imaging test that doctors traditionally use to evaluate patients for cancer, but it requires a dose of radiation, and a patient needs to lie still for 30 minutes or more. If ...
Dr George Owiti, a radiographer at Kericho County Hospital examines the Chest CT results of a patient admitted to the hospital. [James Wanzala, Standard] Despite recent breakthroughs that have ...
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...
New PSMA PET/CT can detect signs of prostate cancer within elderly patients without the need of a biopsy. PSMA PET/CT scans can detect signs of prostate cancer in elderly patients without the need of ...
PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...
PET/CT scans are crucial for staging, treatment response monitoring, and detecting extramedullary disease in multiple myeloma patients undergoing CAR T-cell therapy. Bone-independent extramedullary ...
A new piece of high-tech equipment at The Valley Hospital aims to make patients more comfortable while “significantly” improving disease detection. The Ridgewood health care center announced Dec. 6 ...
Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer ...
A positron emission tomography (PET) scan is a nuclear diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat ...
Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.
For years, prostate cancer specialists hit a wall when prostate-specific antigen (PSA) levels crept up after definitive treatment. The cancer was likely back — but where? And to what extent? Bone plus ...